Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Esketamine Versus Crisis Response Planning Versus Enhanced Treatment as Usual for Suicide Prevention: A Pragmatic Randomized Trial in a Brazilian Municipality (SAVE)

NCT07120477 is registered in ClinicalTrials.gov with University of Sao Paulo as lead sponsor.

NCT NCT07120477
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07120477 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Esketamine Versus Crisis Response Planning Versus Enhanced Treatment as Usual for Suicide Prevention: A Pragmatic Randomized Trial in a Brazilian Municipality (SAVE)
Lead sponsor
University of Sao Paulo
Phase
Phase 4
Overall status
Recruiting
Start date
June 1, 2026
Completion date
December 31, 2029
Enrollment
478 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

crisis response plan, ketamine, suicide prevention